Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Severe Cutaneous Adverse Drug Reactions Associated with Allopurinol: An Analysis of Spontaneous Reporting System in Southern Italy
Cristina Scavone, Cristina Di Mauro, Rosanna Ruggiero, et al.
Drugs - Real World Outcomes (2019) Vol. 7, Iss. 1, pp. 41-51
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Covid-19 Kills More Men Than Women: An Overview of Possible Reasons
Annalisa Capuano, Francesco Rossi, Giuseppe Paolisso
Frontiers in Cardiovascular Medicine (2020) Vol. 7
Open Access | Times Cited: 94
Pharmacogenomics for Primary Care: An Overview
Victoria Rollinson, Richard M. Turner, Munir Pirmohamed
Genes (2020) Vol. 11, Iss. 11, pp. 1337-1337
Open Access | Times Cited: 45
PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database
Gabriella di Mauro, Alessia Zinzi, Cristina Scavone, et al.
Drug Safety (2020) Vol. 44, Iss. 3, pp. 337-349
Open Access | Times Cited: 35
Investigation of the Inhibition Mechanism of Xanthine Oxidoreductase by Oxipurinol: A Computational Study
Yazdan Maghsoud, Chao Dong, G. Andrés Cisneros
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 13, pp. 4190-4206
Open Access | Times Cited: 10
The Reporting Frequency of Ketoacidosis Events with Dapagliflozin from the European Spontaneous Reporting System: The DAPA-KETO Study
Gabriella di Mauro, Annamaria Mascolo, Mario Gaio, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 3, pp. 286-286
Open Access | Times Cited: 14
Neurological Manifestations Related to Immune Checkpoint Inhibitors: Reverse Translational Research by Using the European Real-World Safety Data
Rosanna Ruggiero, Barbara Stelitano, Federica Fraenza, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 13
Allopurinol-induced hypersensitivity reaction in a patient of underlying renal impairment
Rohit R. Hemnani, Shikha V. Sood, Sapna D. Gupta, et al.
National Journal of Pharmacology and Therapeutics (2024) Vol. 2, Iss. 1, pp. 41-44
Closed Access | Times Cited: 2
Skin Toxicities Associated with Botulin Toxin Injection for Aesthetic Procedures: Data from the European Spontaneous Reporting System
Maria Maddalena Nicoletti, Antonietta Anatriello, Valerio Liguori, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1611-1611
Open Access | Times Cited: 6
Analysis of Individual Case Safety Reports of Severe Cutaneous Adverse Reactions in Korea
Min‐Gyu Kang, Kyoung‐Hee Sohn, Dong Yoon Kang, et al.
Yonsei Medical Journal (2019) Vol. 60, Iss. 2, pp. 208-208
Open Access | Times Cited: 16
Did the COVID-19 Pandemic Affect Contrast Media-Induced Adverse Drug Reaction’s Reporting? A Pharmacovigilance Study in Southern Italy
Cláudia Rossi, Rosanna Ruggiero, Liberata Sportiello, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 17, pp. 5104-5104
Open Access | Times Cited: 8
Hepatobiliary Adverse Reactions during Treatment with Cladribine: Analysis of Data from the European Spontaneous Reporting System
Elena Mirabela Velișcu, Valerio Liguori, Antonietta Anatriello, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 8, pp. 1071-1071
Open Access | Times Cited: 4
T-Cell malignancies following CAR T-Cell therapy: insights from the FDA adverse event reporting system (FAERS)
Raffaella Di Napoli, Nunzia Balzano, Rosanna Ruggiero, et al.
Expert Opinion on Drug Safety (2024)
Closed Access | Times Cited: 1
Stevens-Johnson Syndrome From Combined Allopurinol and Angiotensin-Converting Enzyme Inhibitors: A Narrative Review
Isabella M Fabian, Kirsten Maddox, Cameron Robicheaux, et al.
Cureus (2024)
Open Access | Times Cited: 1
Implementing HLA-B*58:01 testing prior to allopurinol initiation in Malaysian primary care setting: A qualitative study from doctors’ and patients’ perspective
Wei Leik Ng, Norita Hussein, Chirk Jenn Ng, et al.
PLoS ONE (2024) Vol. 19, Iss. 1, pp. e0296498-e0296498
Open Access | Times Cited: 1
Tisagenlecleucel in Children and Young Adults: Reverse Translational Research by Using Real-World Safety Data
Concetta Rafaniello, Carmen Ferrajolo, Mario Gaio, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 9, pp. 258-258
Open Access | Times Cited: 10
Preliminary Results of the FASM Study, an On-Going Italian Active Pharmacovigilance Project
Giorgia Teresa Maniscalco, Vincenzo Brescia Morra, Ciro Florio, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 12, pp. 466-466
Open Access | Times Cited: 9
Allopurinol induced severe cutaneous adverse reactions: Vigilance of prescription (31 cases)
F. Hali, H. Chagraoui, A. Meftah, et al.
Revue française d'allergologie (2023) Vol. 63, Iss. 2, pp. 103275-103275
Closed Access | Times Cited: 3
Allopurinol-Induced Severe Cutaneous Adverse Drug Reactions: An Analysis of Spontaneous Reports in Malaysia (2000–2018)
Sing Chet Lee, Wee Kee Wo, Hee Sheong Yeoh, et al.
Therapeutic Innovation & Regulatory Science (2021) Vol. 55, Iss. 3, pp. 514-522
Closed Access | Times Cited: 7
Allopurinol‐induced Stevens‐Johnson syndrome and toxic epidermal necrolysis: Signal detection and preventability from Vietnam National pharmacovigilance database
Phung Thanh Huong, Nhu Phuc Tran, Trần Thị Quỳnh Như, et al.
Journal of Clinical Pharmacy and Therapeutics (2022) Vol. 47, Iss. 12, pp. 2014-2019
Closed Access | Times Cited: 3
Is pancreatitis associated with meglumine antimoniate treatment for canine leishmaniosis? A multicentric prospective study
Clàudia Viñeta, Jorge Castro, María Cristina Lorente López, et al.
Parasites & Vectors (2024) Vol. 17, Iss. 1
Open Access
Computational Insights into the Inhibition Mechanism of Xanthine Oxidoreductase by Oxipurinol
Yazdan Maghsoud, Chao Dong, G. Andrés Cisneros
(2023)
Open Access | Times Cited: 1
Characteristics of DRESS Syndrome in the Elderly: A Comparative Study of 55 Patients
E. Bahloul, Khaoula Trimeche, Khadija Sellami, et al.
Dermatitis (2023) Vol. 35, Iss. 1, pp. 55-60
Closed Access | Times Cited: 1
Photodistributed erythema multiforme in a polymedicated patient
María López‐Pardo Rico, Cecilia Buján Bonino, Noelia Moreiras Arias, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2023) Vol. 21, Iss. 12, pp. 1557-1559
Closed Access | Times Cited: 1
Immune Checkpoint Inhibitors and Scleroderma: Data from the European Pharmacovigilance Database
Maria Maddalena Nicoletti, Erminia Crisci, Vincenzo Cosenza, et al.
Drugs - Real World Outcomes (2023) Vol. 11, Iss. 1, pp. 33-41
Open Access | Times Cited: 1
Methods for Identifying Culprit Drugs in Cutaneous Drug Eruptions: A Scoping Review
Reetesh Bose, Selam Ogbalidet, Mina Boshra, et al.
Journal of Cutaneous Medicine and Surgery (2021) Vol. 26, Iss. 2, pp. 162-168
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top